MAPT and Alzheimer disease: Under pathological conditions, when these enzymes are overexpressed, ACh can be over-degraded, and many factors important in the development of AD may be affected (e.g., β-amyloid formation, tau protein phosphorylation, or neuroinflammation) [5].